VIMCO (Canada)
This treatment applies to the following species:Staphylococcus Aureus Bacterin
Composition
Inactivated culture of Staph. aureus containing high amounts of biofilm. Contains benzyl alcohol as a preservative.
Staphylococcal bacteria are the most prevalent pathogen causing mastitis in goats. These staphylococci are frequently biofilm producers. Biofilm is a slime produced by these bacteria which helps protect them against antibiotics and the immune system. VIMCO has a high biofilm producing S. aureus strain which allows antibody production not only against S. aureus but against staphylococcal biofilm.
VIMCO Indications
This product has been shown to be effective for the vaccination of healthy goats 28 weeks of age or older against mastitis caused by Staphylococcus aureus.
Contraindications
None.
Adverse Reactions
Transient injection site swelling may be observed at the vaccination site.
ADMINISTRATION ROUTE AND DOSAGE:
Administer one dose (2 ml) by deep intramuscular injection in the neck muscles at 5 weeks before the expected parturition date and 3 weeks thereafter administer a second dose.
Repeat the same two dose regimen for subsequent parturitions.
WITHDRAWAL PERIOD:
Do not vaccinate within 60 days before slaughter.
SPECIAL PRECAUTIONS:
Administer the vaccine at a room temperature between +15 °C - +25 °C.
Shake before use.
Store and transport refrigerated at +2 °C - +8 °C).
Do not freeze. Protect from the light.
Use entire contents when first opened.
Do not mix with other products except as specified on the label.
In case of human exposure, contact a physician.
ADDITIONAL INFORMATION:
Packaging:
5 doses (10 mL);
25 doses (50 mL);
50 doses (100 mL).
FOR ANIMAL TREATMENT ONLY
Est. Lic. No.: 4.242-E
Distributed in Canada by: HIPRA ANIMAL HEALTH CANADA INC, 11 Holland Avenue, suite 605 - Ottawa, Ontario K1Y 4S1
Tel 613.422.7610
Manufactured by: LABORATORIOS HIPRA, S.A. Avda. la Selva, 135 . 17170 Amer (Girona) Spain
Tel. (34) 972 43 06 60. Fax (34) 972 43 06 61. hipra@hipra.com
725851-00.1
03-20
CPN: 1905008.0
1420 BLAIR TOWERS PL, SUITE 602, OTTAWA, ON, K1J 9L8
Telephone: | 613-422-7610 | |
Website: | www.hipra.com | |
Email: | cservice.hforceca@hipra.com |
![]() |
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details. |
Copyright © 2025 Animalytix LLC. Updated: 2025-05-29
Elsewhere on our site...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Phentermine
Phentermine is an appetite suppressant used together with diet and exercise to treat obesity. Learn ...
Semaglutide
Semaglutide is a GLP-1 agonist used for weight loss, type 2 diabetes, and reducing cardiovascular ...